Correlation of vitamin D level with the clinical-radiological severity of COVID-19 in geriatric patients

{ 'indexed': {'date-parts': [[2022, 7, 9]], 'date-time': '2022-07-09T13:37:50Z', 'timestamp': 1657373870418}, 'reference-count': 37, 'publisher': 'Journal of Health Sciences and Medicine', 'issue': '3', 'content-domain': {'domain': [], 'crossmark-restriction': False}, 'accepted': {'date-parts': [[2022, 4, 4]]}, 'abstract': '<jats:p xml:lang="en">Objective: This study was planned to investigate the effect of ' '25-OH-Vitamin D (Vit D) deficiency on clinical and radiological findings of coronavirus ' 'disease-2019 (COVID-19) in geriatric patients hospitalized due to COVID-19.&#x0D;\n' 'Material and Method: Seventy-five patients who were treated for COVID-19 were reviewed ' 'retrospectively, and grouped in relation with their ages [(1) 65-74, (2) 75-84, (3) &gt;84 ' 'years] and the severity of Vit D deficiency [(1) severe deficiency: 30 ng/mL]. The complaints ' 'on admission, comorbidities, intensive care unit (ICU) need, length of hospital stay, ' 'laboratory data, and mortality of the ones who had and did not have Vit D replacement ' '(n=18/75) were recorded. The patients were analyzed for COVID-19 severity using radiological ' 'and clinical markers. &#x0D;\n' 'Results: Moderate Vit D deficiency (10-20 ng/mL) was frequently detected. When the disease ' 'severity and Vit D levels were analyzed, it was found that the disease was more severe ' '(46.6%) in the Vit D 30 ng/ml group, but there was no statistically significant difference ' 'among the groups. Low or high Vit D levels did not show any significant correlations with the ' 'severity of pneumonia or the thorax CT findings. The intensive care unit (ICU) admission rate ' 'was significantly lower in those who had Vit D replacement (p</jats:p>', 'DOI': '10.32322/jhsm.1063405', 'type': 'journal-article', 'created': {'date-parts': [[2022, 5, 31]], 'date-time': '2022-05-31T09:48:02Z', 'timestamp': 1653990482000}, 'page': '771-777', 'source': 'Crossref', 'is-referenced-by-count': 0, 'title': 'Correlation of vitamin D level with the clinical-radiological severity of COVID-19 in geriatric ' 'patients', 'prefix': '10.32322', 'volume': '5', 'author': [ { 'given': 'Hüsnü', 'family': 'BAYKAL', 'sequence': 'first', 'affiliation': [ { 'name': 'SAĞLIK BİLİMLERİ ÜNİVERSİTESİ, ANKARA ATATÜRK GÖĞÜS HASTALIKLARI ' 'VE GÖĞÜS CERRAHİSİ SAĞLIK UYGULAMA VE ARAŞTIRMA MERKEZİ, DAHİLİ ' 'TIP BİLİMLERİ BÖLÜMÜ, GÖĞÜS HASTALIKLARI ANABİLİM DALI'}]}, { 'given': 'Ayşe Füsun', 'family': 'ÜLGER', 'sequence': 'additional', 'affiliation': [ { 'name': 'SAĞLIK BİLİMLERİ ÜNİVERSİTESİ, ANKARA ATATÜRK GÖĞÜS HASTALIKLARI ' 'VE GÖĞÜS CERRAHİSİ SAĞLIK UYGULAMA VE ARAŞTIRMA MERKEZİ, DAHİLİ ' 'TIP BİLİMLERİ BÖLÜMÜ, GÖĞÜS HASTALIKLARI ANABİLİM DALI'}]}], 'member': '17352', 'published-online': {'date-parts': [[2022, 5, 30]]}, 'reference': [ { 'key': 'ref1', 'doi-asserted-by': 'crossref', 'unstructured': 'Glinsky GV. Tripartite combination of candidate pandemic mitigation ' 'agents: vitamin D, Quercetin, and Estradiol manifest properties of ' 'medicinal agents for targeted mitigation of the COVID-19 pandemic ' 'defined by genomics-guided tracing of SARS-CoV-2 targets in human cells. ' 'Biomedicines 2020; 8: 129.', 'DOI': '10.3390/biomedicines8050129'}, { 'key': 'ref2', 'doi-asserted-by': 'crossref', 'unstructured': 'Ilie PC, Stefanescu S, Smith L. The role of vitamin D in the prevention ' 'of coronavirus disease 2019 infection and mortality. Aging Clin Exp Res ' '2020; 32: 1195-98.', 'DOI': '10.1007/s40520-020-01570-8'}, { 'key': 'ref3', 'doi-asserted-by': 'crossref', 'unstructured': 'Annweiler G, Corvaisier M, Gautier J, et al. Vitamin D supplementation ' 'associated to better survival in hospitalized frail elderly COVID-19 ' 'patients: The GERIA-COVID quasi-experimental study. Nutrients 2020; 12: ' '3377.', 'DOI': '10.3390/nu12113377'}, { 'key': 'ref4', 'doi-asserted-by': 'crossref', 'unstructured': 'EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA). ' 'Scientific Opinion on the substantiation of health claims related to ' 'vitamin D and normal function of the immune system and inflammatory ' 'response (ID 154, 159), maintenance of normal muscle function (ID 155) ' 'and maintenance of normal cardiovascular function (ID 159) pursuant to ' 'Article 13(1) of Regulation (EC) No 1924/2006. EFSA J 2010; 8: 1-17.', 'DOI': '10.2903/j.efsa.2010.1468'}, { 'key': 'ref5', 'doi-asserted-by': 'crossref', 'unstructured': "Sassi F, Tamone C, D'Amelio P. Vitamin D: nutrient, hormone, and " 'immunomodulator. Nutrients 2018; 10: 1656.', 'DOI': '10.3390/nu10111656'}, { 'key': 'ref6', 'doi-asserted-by': 'crossref', 'unstructured': 'Grant WB, Lahore H, McDonnell SL, et al. Evidence that vitamin D ' 'supplementation could reduce risk of influenza and COVID-19 infections ' 'and deaths. Nutrients 2020; 12: 988.', 'DOI': '10.3390/nu12040988'}, { 'key': 'ref7', 'doi-asserted-by': 'crossref', 'unstructured': 'Sloka S, Silva C, Wang J, Yong VW. Predominance of Th2 polarization by ' 'vitamin D through a STAT6-dependent mechanism. J Neuroinflammation 2011; ' '8: 56.', 'DOI': '10.1186/1742-2094-8-56'}, { 'key': 'ref8', 'doi-asserted-by': 'crossref', 'unstructured': 'Bertoldi G, Gianesello L, Calò LA. Letter: ACE2, Rho kinase inhibition ' 'and the potential role of vitamin D against COVID-19. Aliment Pharmacol ' 'Ther 2020; 52: 577-8.', 'DOI': '10.1111/apt.15895'}, { 'key': 'ref9', 'doi-asserted-by': 'crossref', 'unstructured': 'Huang C, Wang Y, Li X, et al. Clinical features of patients infected ' 'with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395: 497-506.', 'DOI': '10.1016/S0140-6736(20)30183-5'}, { 'key': 'ref10', 'doi-asserted-by': 'crossref', 'unstructured': 'Daneshkhah A, Agrawal V, Eshein A, Subramanian H, Roy HK, Backman V. ' 'Evidence for possible association of vitamin D status with cytokine ' 'storm and unregulated inflammation in COVID-19 patients. Aging Clin Exp ' 'Res 2020; 32: 2141-58.', 'DOI': '10.1007/s40520-020-01677-y'}, { 'key': 'ref11', 'doi-asserted-by': 'crossref', 'unstructured': 'Rhodes JM, Subramanian S, Laird E, Griffin G, Kenny RA. Perspective: ' 'Vitamin D deficiency and COVID-19 severity-plausibly linked by latitude, ' 'ethnicity, impacts on cytokines, ACE2 and thrombosis. J Intern Med 2021; ' '289: 97-115.', 'DOI': '10.1111/joim.13149'}, { 'key': 'ref12', 'doi-asserted-by': 'crossref', 'unstructured': 'Wyskida M, Wieczorowska-Tobis K, Chudek J. Prevalence and factors ' 'promoting the occurrence of vitamin D deficiency in the elderly. Postepy ' 'Hig Med Dosw (Online) 2017; 71: 198-204.', 'DOI': '10.5604/01.3001.0010.3804'}, { 'key': 'ref13', 'doi-asserted-by': 'crossref', 'unstructured': 'Cheng Q, Du Y, Hong W, et al. Factors associated to serum ' '25-hydroxyvitamin D levels among older adult populations in urban and ' 'suburban communities in Shanghai, China. BMC Geriatr 2017; 17: 246.', 'DOI': '10.1186/s12877-017-0632-z'}, { 'key': 'ref14', 'doi-asserted-by': 'crossref', 'unstructured': 'Zhao M. Cytokine storm and immunomodulatory therapy in COVID-19: Role of ' 'chloroquine and anti-IL-6 monoclonal antibodies. Int J Antimicrob Agents ' '2020; 55: 105982.', 'DOI': '10.1016/j.ijantimicag.2020.105982'}, { 'key': 'ref15', 'doi-asserted-by': 'crossref', 'unstructured': 'Ebadi M, Montano-Loza AJ. Perspective: improving vitamin D status in the ' 'management of COVID-19. Eur J Clin Nutr 2020; 74: 856-9.', 'DOI': '10.1038/s41430-020-0661-0'}, { 'key': 'ref16', 'doi-asserted-by': 'crossref', 'unstructured': 'Im JH, Je YS, Baek J, Chung MH, Kwon HY, Lee JS. Nutritional status of ' 'patients with COVID-19. Int J Infect Dis 2020; 100: 390-3.', 'DOI': '10.1016/j.ijid.2020.08.018'}, { 'key': 'ref17', 'doi-asserted-by': 'crossref', 'unstructured': 'Maghbooli Z, Sahraian MA, Ebrahimi M, et al. Vitamin D sufficiency, a ' 'serum 25-hydroxyvitamin D at least 30 ng/mL reduced risk for adverse ' 'clinical outcomes in patients with COVID-19 infection. PLoS One 2020; ' '15: e0239799.', 'DOI': '10.1371/journal.pone.0239799'}, { 'key': 'ref18', 'doi-asserted-by': 'crossref', 'unstructured': 'Hastie CE, Mackay DF, Ho F, et al. Vitamin D concentrations and COVID-19 ' 'infection in UK Biobank. Diabetes Metab Syndr 2020; 14: 561-5.', 'DOI': '10.1016/j.dsx.2020.04.050'}, { 'key': 'ref19', 'doi-asserted-by': 'crossref', 'unstructured': 'Oscanoa TJ, Amado J, Vidal X, Laird E, Ghashut RA, Romero-Ortuno R. The ' 'relationship between the severity and mortality of SARS-CoV-2 infection ' 'and 25-hydroxyvitamin D concentration-a metaanalysis. Adv Respir Med ' '2021; 89: 145-57.', 'DOI': '10.5603/ARM.a2021.0037'}, { 'key': 'ref20', 'doi-asserted-by': 'crossref', 'unstructured': 'Yildiz M, Senel MU, Kavurgaci S, Ozturk FE, Ozturk A. The prognostic ' 'significance of vitamin D deficiency in patients with COVID-19 ' 'pneumonia. Bratisl Lek Listy 2021; 122: 744-7.', 'DOI': '10.4149/BLL_2021_119'}, { 'key': 'ref21', 'doi-asserted-by': 'crossref', 'unstructured': 'Hastie CE, Pell JP, Sattar N. Vitamin D and COVID-19 infection and ' 'mortality in UK Biobank. Eur J Nutr 2021; 60: 545-8.', 'DOI': '10.1007/s00394-020-02372-4'}, { 'key': 'ref22', 'doi-asserted-by': 'crossref', 'unstructured': 'Kweder H, Eidi H. Vitamin D deficiency in elderly: Risk factors and ' 'drugs impact on vitamin D status. Avicenna J Med 2018; 8: 139-46.', 'DOI': '10.4103/ajm.AJM_20_18'}, { 'key': 'ref23', 'doi-asserted-by': 'crossref', 'unstructured': 'Hanley DA, Cranney A, Jones G, et al; Guidelines committee of the ' 'scientific advisory council of osteoporosis Canada. Vitamin D in adult ' 'health and disease: a review and guideline statement from Osteoporosis ' 'Canada. CMAJ 2010; 182: E610-8.', 'DOI': '10.1503/cmaj.080663'}, { 'key': 'ref24', 'doi-asserted-by': 'crossref', 'unstructured': 'Simpson S, Kay FU, Abbara S, et al. Radiological Society of North ' 'America Expert Consensus Statement on Reporting Chest CT Findings ' 'Related to COVID-19. Endorsed by the Society of Thoracic Radiology, the ' 'American College of Radiology, and RSNA-Secondary Publication. J Thorac ' 'Imaging 2020; 35: 219-27.', 'DOI': '10.1097/RTI.0000000000000524'}, { 'key': 'ref25', 'doi-asserted-by': 'crossref', 'unstructured': 'Bulut S, Karamanlı H, Şahin ME, Çelik D, Biber Ç. Association between ' 'vitamin D levels and frequency of disease exacerbations and ' 'hospitalizations in patients with COPD. J Health Sci Med 2022; 5: 471-7.', 'DOI': '10.32322/jhsm.1050722'}, { 'key': 'ref26', 'doi-asserted-by': 'crossref', 'unstructured': 'De Smet D, De Smet K, Herroelen P, Gryspeerdt S, Martens GA. Serum ' '25(OH)D level on hospital admission associated with COVID-19 stage and ' 'mortality. Am J Clin Pathol 2021; 155: 381-8.', 'DOI': '10.1093/ajcp/aqaa252'}, { 'key': 'ref27', 'doi-asserted-by': 'crossref', 'unstructured': 'Bassatne A, Basbous M, Chakhtoura M, El Zein O, Rahme M, El-Hajj ' 'Fuleihan G. The link between COVID-19 and Vitamin D (VIVID): a ' 'systematic review and meta-analysis. Metabolism 2021; 119: 154753.', 'DOI': '10.1016/j.metabol.2021.154753'}, { 'key': 'ref28', 'doi-asserted-by': 'crossref', 'unstructured': 'Baktash V, Hosack T, Patel N, et al. Vitamin D status and outcomes for ' 'hospitalized older patients with COVID-19. Postgrad Med J 2021; 97: ' '442-7.', 'DOI': '10.1136/postgradmedj-2020-138712'}, { 'key': 'ref29', 'doi-asserted-by': 'crossref', 'unstructured': 'Sulli A, Gotelli E, Casabella A, et al. Vitamin D and lung outcomes in ' 'elderly COVID-19 patients. Nutrients 2021; 13: 717.', 'DOI': '10.3390/nu13030717'}, { 'key': 'ref30', 'doi-asserted-by': 'crossref', 'unstructured': 'Cereda E, Bogliolo L, Klersy C, Lobascio F, Masi S, Crotti S. Vitamin D ' '25OH deficiency in COVID-19 patients admitted to a tertiary referral ' 'hospital. Clin Nutr 2021; 40: 2469-72.', 'DOI': '10.1016/j.clnu.2020.10.055'}, { 'key': 'ref31', 'doi-asserted-by': 'crossref', 'unstructured': 'Hernandez JL, Nan D, Fernandez-Ayala M, Garcia-Unzueta M, ' 'Hernandez-Hernandez MA, Lopez-Hoyos M. Vitamin D status in hospitalized ' 'patients with SARS-CoV-2 infection. J Clin Endocrinol Metab 2021; 106: ' 'e1343. e135.', 'DOI': '10.1210/clinem/dgaa733'}, { 'key': 'ref32', 'doi-asserted-by': 'crossref', 'unstructured': 'Jain A, Chaurasia R, Sengar NS, Singh M, Mahor S, Narain S. Analysis of ' 'vitamin D level among asymptomatic and critically ill COVID-19 patients ' 'and its correlation with inflammatory markers. Sci Rep 2020; 10: 1-8.', 'DOI': '10.1038/s41598-020-77093-z'}, { 'key': 'ref33', 'doi-asserted-by': 'crossref', 'unstructured': 'Ohaegbulam KC, Swalih M, Patel P, Smith MA, Perrin R. Vitamin D ' 'supplementation in COVID-19 patients: a clinical case series. Am J Ther ' '2020; 27: e485-90.', 'DOI': '10.1097/MJT.0000000000001222'}, { 'key': 'ref34', 'doi-asserted-by': 'crossref', 'unstructured': 'Shah K, Saxena D, Mavalankar D. Vitamin D supplementation, COVID-19 and ' 'disease severity: a meta-analysis. QJM 2021; 114: 175-81.', 'DOI': '10.1093/qjmed/hcab009'}, { 'key': 'ref35', 'doi-asserted-by': 'crossref', 'unstructured': 'Panagiotou G, Tee SA, Ihsan Y, et al. Low serum 25-hydroxyvitamin D ' '(25[OH]D) levels in patients hospitalized with COVID-19 are associated ' 'with greater disease severity. Clin Endocrinol (Oxf) 2020; 93: 508-11.', 'DOI': '10.1111/cen.14276'}, { 'key': 'ref36', 'doi-asserted-by': 'crossref', 'unstructured': 'Tan CW, Ho LP, Kalimuddin S, Cherng BPZ, Teh YE, Thien SY. A cohort ' 'study to evaluate the effect of combination Vitamin D, Magnesium and ' 'Vitamin B12 (DMB) on progression to severe outcome in older COVID-19 ' 'patients. medRxiv 2020', 'DOI': '10.1101/2020.06.01.20112334'}, { 'key': 'ref37', 'doi-asserted-by': 'crossref', 'unstructured': 'Murai IH, Fernandes AL, Sales LP, Pinto AJ, Goessler KF, Duran CS. ' 'Effect of a single high dose of vitamin D3 on hospital length of stay in ' 'patients with moderate to severe COVID-19: a randomized clinical trial. ' 'JAMA 2021; 17: 2021.', 'DOI': '10.1001/jama.2020.26848'}], 'container-title': 'Journal of Health Sciences and Medicine', 'original-title': [], 'language': 'en', 'deposited': { 'date-parts': [[2022, 5, 31]], 'date-time': '2022-05-31T09:48:18Z', 'timestamp': 1653990498000}, 'score': 1, 'resource': {'primary': {'URL': 'https://dergipark.org.tr/en/doi/10.32322/jhsm.1063405'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2022, 5, 30]]}, 'references-count': 37, 'journal-issue': {'issue': '3', 'published-online': {'date-parts': [[2022, 5, 30]]}}, 'URL': 'http://dx.doi.org/10.32322/jhsm.1063405', 'relation': {}, 'ISSN': ['2636-8579'], 'subject': ['General Medicine'], 'container-title-short': 'J Health Sci Med / JHSM', 'published': {'date-parts': [[2022, 5, 30]]}}